Future work should investigate increased CPSF1 dosage effects experiments and assess whether CPSF1 targeting (both genetically and pharmacologically) reveals therapeutic vulnerabilities in CPSF1-amplified cancers. The gene discussed is CPSF1; the disease is cancer.